Artificial oocyte activation may improve embryo quality in older patients with diminished ovarian reserve undergoing IVF-ICSI cycles

• Main Authors: Tzung-En Tsai (Author), Pei-Hsuan Lin (Author), Pei-Fen Lian (Author), Chia-Jung Li (Author), Salvatore Giovanni Vitale (Author), Mislav Mikuš (Author), Wan-Ping Su (Author), Hsiao-Wen Tsai (Author), Kuan-Hao Tsui (Author), Li-Te Lin (Author)
• Format: Book
• Published: BMC, 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Artificial oocyte activation (AOA) is used to improve fertilization rate following fertilization failure after intracytoplasmic sperm injection (ICSI). Several studies have also shown that AOA may be involved in embryo development. Women with poor ovarian response are more likely...